This inventor holds 2 USPTO granted patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Vladimir Brusic: Innovator in Peptide Identification and Tissue Typing
Introduction
Vladimir Brusic is a notable inventor based in Brookline, MA, who has made significant contributions to the fields of immunology and tissue typing. With a total of two patents to his name, his work focuses on the identification of conserved peptide blocks in homologous polypeptides and the development of oligonucleotide arrays for tissue typing.
Latest Patents
Brusic's latest patents include "Identification of conserved peptide blocks in homologous polypeptides," which provides methods for identifying conserved peptide blocks in three or more homologous polypeptides. This invention is particularly relevant for selecting conserved peptides in variable viral polypeptides for use in immunogenic compositions. His second patent, "Oligonucleotide array for tissue typing," presents oligonucleotide-based microarrays designed for high-resolution tissue typing, such as HLA tissue typing. These microarrays are essential for diagnostic evaluations and determining donor/recipient transplant compatibility.
Career Highlights
Vladimir Brusic is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in his areas of expertise. His work has implications for improving transplant compatibility and enhancing immunogenic responses.
Collaborations
Brusic has collaborated with esteemed colleagues, including Ellis L. Reinherz and Guanglan Zhang, contributing to a rich environment of innovation and research.
Conclusion
Vladimir Brusic's contributions to peptide identification and tissue typing underscore his role as a significant inventor in the field. His patents reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
